-
Golden Jubilee National Hospital, as appropriate 10. The Fellow will be expected to register for a higher degree (e.g., MD or PhD) and the work is expected to contribute to the basis for submission of a
-
analyses carried out by the School of Cancer Sciences. This covers all GCLP aspects of the Translational Pharmacology Laboratory, based at the WWCRC, the GTRF based at the Queen Elizabeth University Hospital
-
common and rare human diseases and regenerative medicine and facilitate development of new therapeutics in molecular pharmacology. We have a breadth of expertise in multi-disciplinary integrative biology
-
the clinical potential of these compounds and define the best strategies for designing their clinical implementation. The candidate will develop skills in cell culturing, with particular reference to 3D models
-
(Research): 1 year full-time; 2 years part-time; IPhD: 5 years full-time; Apply now Overview Overview Our PhD programmes offer training in all aspects of molecular pharmacology and our large internationally
-
, research is vital to advance diagnosis, treatment and prevention. Our strength is in identifying and designing novel therapeutic strategies that will lead to clinical trials. PhD: 3-4 years full-time; 5
-
clinical trials Study options Study options PhD Duration: 3/4 years full-time; 5 years part-time Individual research projects are tailored around the expertise of principal investigators. Integrated PhD
-
systems to the brain imaging of human behaviour and cognition as well as social level investigations. PhD: 3-4 years full-time; 5 years part-time; MD (Doctor of Medicine): 2 years full-time; 4 years part